Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2001 AND VI 15 AND IP 6
Results: 10
1
2
Aetiology and treatment of sleep disturbances during perimenopause and postmenopause.
- Published in:
- 2001
- By:
- Publication type:
- journal article
3
Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression.
- Published in:
- 2001
- By:
- Publication type:
- journal article
4
Homocysteine levels in patients with stroke: clinical relevance and therapeutic implications.
- Published in:
- 2001
- By:
- Publication type:
- journal article
5
Methylphenidate (OROS formulation).
- Published in:
- 2001
- By:
- Publication type:
- journal article
6
Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective.
- Published in:
- 2001
- By:
- Publication type:
- journal article
7
Methylphenidate (OROS[sup ®] Formulation).
- Published in:
- CNS Drugs, 2001, v. 15, n. 6, p. 495, doi. 10.2165/00023210-200115060-00006
- By:
- Publication type:
- Article
8
Methylphenidate (OROS[sup ®] Formulation): A Viewpoint by Marsha D. Rappley.
- Published in:
- CNS Drugs, 2001, v. 15, n. 6, p. 501, doi. 10.2165/00023210-200115060-00007
- By:
- Publication type:
- Article
9
Methylphenidate (OROS[sup ®] Formulation): A Viewpoint by Christopher K. Varley.
- Published in:
- CNS Drugs, 2001, v. 15, n. 6, p. 501, doi. 10.2165/00023210-200115060-00008
- By:
- Publication type:
- Article
10
Methylphenidate (OROS[sup ®] Formulation): A Viewpoint by James M. Swanson, Marc Lerner, Kenneth Steinhoff and Sharon Wigal.
- Published in:
- CNS Drugs, 2001, v. 15, n. 6, p. 501, doi. 10.2165/00023210-200115060-00009
- By:
- Publication type:
- Article